Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jordan B Singleton

1PUBLICATIONS

8CO-AUTHORS

Major global burdens of disease

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Nov 29, 2024

Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024.

Jordan B Singleton, Dennis Wang, Souci Louis

Pageof 1

Frequent Collaborators

1 joint publications

Dennis Wang

1 joint publications

Souci Louis

1 joint publications

Dallas J Smith

1 joint publications

Anastasia S Lambrou

1 joint publications

Susan E Beekmann

1 joint publications

Shikha Garg

1 joint publications

Timothy M Uyeki

1 joint publications

Scott Santibañez

Frequent Collaborators

1 joint publications

Dennis Wang

1 joint publications

Souci Louis

1 joint publications

Dallas J Smith

1 joint publications

Anastasia S Lambrou

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

See more related videos